Will This ETF Beat the Market Over the Next 12 Months?
2024 was another banner year for the US stock market,…
Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
---|---|---|---|---|---|---|
Revenue | $30.5M | $26.4M | $34.5M | $35.4M | $42.2M | |
Revenue Growth (YoY) | -- | -13.58% | 30.62% | 2.61% | 19.25% | |
Cost of Revenues | $17.3M | $12.3M | $16.6M | $15.4M | $21.1M | |
Gross Profit | $13.2M | $14.1M | $17.8M | $20M | $21.1M | |
Gross Profit Margin | 43.33% | 53.35% | 51.75% | 56.44% | 50.06% | |
R&D Expenses | $7.6M | $7.6M | $12.4M | $11.8M | $6.1M | |
Selling, General & Admin | $17.1M | $23.8M | $23.9M | $27.2M | $26.1M | |
Other Inc / (Exp) | $58K | $68K | $51K | $263K | -$2.2M | |
Operating Expenses | $25.9M | $32.6M | $37.5M | $40.1M | $33.3M | |
Operating Income | -$12.7M | -$18.5M | -$19.7M | -$20.2M | -$12.2M | |
Net Interest Expenses | $2M | $1.3M | -- | -- | -- | |
EBT. Incl. Unusual Items | -$14.7M | -$19.8M | -$19.6M | -$19.9M | -$14.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$14.7M | -$19.8M | -$19.6M | -$19.9M | -$14.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$14.7M | -$19.8M | -$19.6M | -$19.9M | -$14.4M | |
Basic EPS (Cont. Ops) | -$1.38 | -$4.28 | -$2.09 | -$1.96 | -$1.31 | |
Diluted EPS (Cont. Ops) | -$1.38 | -$4.28 | -$2.09 | -$1.96 | -$1.31 | |
Weighted Average Basic Share | $10.6M | $4.6M | $9.4M | $10.2M | $11M | |
Weighted Average Diluted Share | $10.6M | $4.6M | $9.4M | $10.2M | $11M | |
EBITDA | -$8.8M | -$15.9M | -$16.9M | -$16.8M | -$8.7M | |
EBIT | -$12.7M | -$18.4M | -$19.7M | -$20.2M | -$12.2M | |
Revenue (Reported) | $30.5M | $26.4M | $34.5M | $35.4M | $42.2M | |
Operating Income (Reported) | -$12.7M | -$18.5M | -$19.7M | -$20.2M | -$12.2M | |
Operating Income (Adjusted) | -$12.7M | -$18.4M | -$19.7M | -$20.2M | -$12.2M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Revenue | $7.1M | $8.3M | $7.7M | $9.8M | $13.5M | |
Revenue Growth (YoY) | -11.44% | 15.77% | -6.34% | 26.42% | 38.22% | |
Cost of Revenues | $3.2M | $4.4M | $3.9M | $4.9M | $7.3M | |
Gross Profit | $3.9M | $3.9M | $3.9M | $4.9M | $6.3M | |
Gross Profit Margin | 54.53% | 46.56% | 50.19% | 49.79% | 46.28% | |
R&D Expenses | $2M | $3.2M | $1.6M | $1.5M | $1.2M | |
Selling, General & Admin | $6.3M | $6.5M | $6.1M | $5.1M | $6.1M | |
Other Inc / (Exp) | $14K | $10K | $92K | $4.6M | -$257K | |
Operating Expenses | $8.6M | $10M | $8M | $6.9M | $7.5M | |
Operating Income | -$4.7M | -$6.2M | -$4.1M | -$2M | -$1.2M | |
Net Interest Expenses | $65K | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$4.8M | -$6.2M | -$4M | $2.6M | -$1.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$4.8M | -$6.2M | -$4M | $2.6M | -$1.5M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$4.8M | -$6.2M | -$4M | $2.6M | -$1.5M | |
Basic EPS (Cont. Ops) | -$0.64 | -$0.65 | -$0.39 | $0.13 | -$0.13 | |
Diluted EPS (Cont. Ops) | -$0.64 | -$0.65 | -$0.39 | -$0.23 | -$0.13 | |
Weighted Average Basic Share | $7.5M | $9.4M | $10.2M | $11.1M | $11.6M | |
Weighted Average Diluted Share | $7.5M | $9.4M | $10.2M | $12M | $11.6M | |
EBITDA | -$4.2M | -$5.5M | -$3.2M | -$1.2M | -$239K | |
EBIT | -$4.7M | -$6.2M | -$4.1M | -$2M | -$1.2M | |
Revenue (Reported) | $7.1M | $8.3M | $7.7M | $9.8M | $13.5M | |
Operating Income (Reported) | -$4.7M | -$6.2M | -$4.1M | -$2M | -$1.2M | |
Operating Income (Adjusted) | -$4.7M | -$6.2M | -$4.1M | -$2M | -$1.2M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Revenue | $26.6M | $31.5M | $36.3M | $40.3M | $48.9M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $12.5M | $14.7M | $17.2M | $17.9M | $25M | |
Gross Profit | $14.1M | $16.9M | $19.1M | $22.4M | $23.9M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $6.4M | $11.5M | $13.6M | $6.3M | $5.5M | |
Selling, General & Admin | $20M | $26.7M | $25.8M | $26.9M | $26M | |
Other Inc / (Exp) | $65K | $61K | $150K | -$1.1M | -$8M | |
Operating Expenses | $27.7M | $39.5M | $40.6M | $34.3M | $32.5M | |
Operating Income | -$13.6M | -$22.6M | -$21.5M | -$11.9M | -$8.6M | |
Net Interest Expenses | $1.9M | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$15.4M | -$22.5M | -$21.3M | -$12.9M | -$16.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -$22.5M | -$21.3M | -$12.9M | -$16.6M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$15.4M | -$22.5M | -$21.3M | -$12.9M | -$16.6M | |
Basic EPS (Cont. Ops) | -$1.64 | -$2.46 | -$2.14 | -$1.32 | -$1.46 | |
Diluted EPS (Cont. Ops) | -$1.64 | -$2.46 | -$2.14 | -$1.68 | -$1.46 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -$10.7M | -$20M | -$18.2M | -$8.4M | -$4.9M | |
EBIT | -$13.5M | -$22.6M | -$21.5M | -$11.9M | -$8.6M | |
Revenue (Reported) | $26.6M | $31.5M | $36.3M | $40.3M | $48.9M | |
Operating Income (Reported) | -$13.6M | -$22.6M | -$21.5M | -$11.9M | -$8.6M | |
Operating Income (Adjusted) | -$13.5M | -$22.6M | -$21.5M | -$11.9M | -$8.6M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Revenue | $18.1M | $23.2M | $25.1M | $30.1M | $36.8M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $8.7M | $11M | $11.7M | $14.1M | $18M | |
Gross Profit | $9.4M | $12.2M | $13.5M | $16M | $18.7M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $5M | $8.9M | $10.2M | $4.7M | $4M | |
Selling, General & Admin | $15.1M | $18.1M | $20M | $19.7M | $19.7M | |
Other Inc / (Exp) | $48K | $41K | $140K | -$1.2M | -$7.1M | |
Operating Expenses | $21.1M | $27.9M | $31M | $25.2M | $24.4M | |
Operating Income | -$11.7M | -$15.7M | -$17.6M | -$9.3M | -$5.6M | |
Net Interest Expenses | $1.3M | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$12.9M | -$15.7M | -$17.4M | -$10.5M | -$12.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -$12.9M | -$15.7M | -$17.4M | -$10.5M | -$12.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$12.9M | -$15.7M | -$17.4M | -$10.5M | -$12.7M | |
Basic EPS (Cont. Ops) | -$1.41 | -$1.68 | -$1.73 | -$1.08 | -$1.11 | |
Diluted EPS (Cont. Ops) | -$1.41 | -$1.68 | -$1.73 | -$1.44 | -$1.11 | |
Weighted Average Basic Share | $28.7M | $27.9M | $30.3M | $32.6M | $34.4M | |
Weighted Average Diluted Share | $28.7M | $27.9M | $30.3M | $33.5M | $34.4M | |
EBITDA | -$9.6M | -$13.7M | -$15M | -$6.7M | -$2.8M | |
EBIT | -$11.6M | -$15.7M | -$17.6M | -$9.3M | -$5.6M | |
Revenue (Reported) | $18.1M | $23.2M | $25.1M | $30.1M | $36.8M | |
Operating Income (Reported) | -$11.7M | -$15.7M | -$17.6M | -$9.3M | -$5.6M | |
Operating Income (Adjusted) | -$11.6M | -$15.7M | -$17.6M | -$9.3M | -$5.6M |
Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $4.6M | $40.6M | $31.6M | $14.7M | $20.6M | |
Short Term Investments | -- | -- | -- | -- | $3.4M | |
Accounts Receivable, Net | $3.4M | $2M | $4.6M | $6M | $4M | |
Inventory | $8.1M | $13.5M | $6.5M | $11.7M | $15.7M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $618K | $1.9M | $1.7M | $1.1M | $2.4M | |
Total Current Assets | $17.2M | $58.4M | $44.8M | $33.7M | $46.4M | |
Property Plant And Equipment | $2.2M | $4.4M | $7.4M | $6.9M | $8.1M | |
Long-Term Investments | -- | -- | -- | -- | $492K | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | $13.4M | $12.1M | $10.9M | $12.1M | $11M | |
Other Long-Term Assets | $1M | $3.8M | $3.2M | $2.7M | $2.2M | |
Total Assets | $34.5M | $79.1M | $66.5M | $55.8M | $69.6M | |
Accounts Payable | $1.6M | $2.5M | $2.7M | $5.4M | $4M | |
Accrued Expenses | $806K | $1.6M | $1.2M | $1.2M | $1.7M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | $493K | $512K | $531K | $559K | |
Other Current Liabilities | $697K | -- | -- | -- | -- | |
Total Current Liabilities | $7.8M | $8.5M | $8.7M | $11.4M | $11.6M | |
Long-Term Debt | $20.2M | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $65.1M | $11.9M | $11.6M | $13.9M | $36.2M | |
Common Stock | $11K | $109K | $110K | $111K | $113K | |
Other Common Equity Adj | -- | -- | -- | -- | $4K | |
Common Equity | -$30.6M | $67.2M | $54.9M | $42M | $33.4M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -$30.6M | $67.2M | $54.9M | $42M | $33.4M | |
Total Liabilities and Equity | $34.5M | $79.1M | $66.5M | $55.8M | $69.6M | |
Cash and Short Terms | $4.6M | $40.6M | $31.6M | $14.7M | $24.1M | |
Total Debt | $20.2M | -- | -- | -- | -- |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $42.7M | $32.3M | $19.3M | $24.9M | $10.4M | |
Short Term Investments | -- | -- | -- | -- | $7.6M | |
Accounts Receivable, Net | $2.4M | $2.8M | $3.6M | $3.8M | $4.4M | |
Inventory | $13.7M | $10.2M | $7.9M | $17.5M | $14.9M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $742K | $1M | $1.3M | $2.1M | $1.7M | |
Total Current Assets | $60M | $46.7M | $32.2M | $48.6M | $39.4M | |
Property Plant And Equipment | $3.8M | $6.7M | $7.4M | $7.4M | $13M | |
Long-Term Investments | -- | -- | -- | -- | $494K | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | $12.4M | $11.2M | $12.4M | $11.3M | $6.3M | |
Other Long-Term Assets | $3.9M | $3.3M | $2.9M | $2.3M | $1.8M | |
Total Assets | $80.7M | $68.1M | $54.8M | $70.9M | $62M | |
Accounts Payable | $2.3M | $2.4M | $3.5M | $3.9M | $3.9M | |
Accrued Expenses | $1.2M | $1.3M | $1.1M | $1.8M | $1.8M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | $526K | $554K | $574K | |
Other Current Liabilities | $1.5M | $507K | $19K | -- | -- | |
Total Current Liabilities | $8.3M | $8M | $9.8M | $11M | $11.7M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $11.8M | $11.1M | $12.2M | $34.5M | $39.3M | |
Common Stock | $106K | $110K | $110K | $112K | $116K | |
Other Common Equity Adj | -- | -- | -- | -- | $15K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -$153K | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $68.9M | $57M | $42.6M | $36.4M | $22.7M | |
Total Liabilities and Equity | $80.7M | $68.1M | $54.8M | $70.9M | $62M | |
Cash and Short Terms | $42.7M | $32.3M | $19.3M | $24.9M | $18.1M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$14.7M | -$19.8M | -$19.6M | -$19.9M | -$14.4M | |
Depreciation & Amoritzation | $3.9M | $2.6M | $2.8M | $3.4M | $3.5M | |
Stock-Based Compensation | $102K | $9M | $6.9M | $6.6M | $5.5M | |
Change in Accounts Receivable | $14K | $1.3M | -$2.7M | -$1.6M | $1.1M | |
Change in Inventories | -$4.8M | -$8.7M | $2.3M | -$6.9M | -$7.5M | |
Cash From Operations | -$12.6M | -$13.8M | -$9M | -$14.9M | -$9.7M | |
Capital Expenditures | $2.1M | $366K | $354K | $115K | $236K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$2.1M | -$326K | -$354K | -$115K | -$4.2M | |
Dividends Paid (Ex Special Dividend) | -$31K | -$1.9M | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $13.2M | $12.4M | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$1.1M | -- | -- | -$2.4M | -- | |
Cash From Financing | $15.9M | $50M | $361K | -$2M | $19.8M | |
Beginning Cash (CF) | $3.4M | $4.7M | $40.6M | $31.6M | $14.7M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $1.3M | $35.9M | -$9M | -$17M | $5.9M | |
Ending Cash (CF) | $4.7M | $40.6M | $31.6M | $14.7M | $20.6M | |
Levered Free Cash Flow | -$14.7M | -$14.2M | -$9.3M | -$15M | -$9.9M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$4.8M | -$6.2M | -$4M | $2.6M | -$1.5M | |
Depreciation & Amoritzation | $540K | $702K | $847K | $882K | $1M | |
Stock-Based Compensation | $3.9M | $1.6M | $1.7M | $1.2M | $668K | |
Change in Accounts Receivable | $161K | -$103K | -$609K | -$202K | $1.6M | |
Change in Inventories | -$2.1M | $569K | -$2.3M | -$675K | -$358K | |
Cash From Operations | -$55K | -$2.1M | -$4.7M | -$339K | $3.2M | |
Capital Expenditures | $6K | $64K | $2K | $2K | $20K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | $14K | -$64K | -$2K | -$2K | -$905K | |
Dividends Paid (Ex Special Dividend) | -$1.8M | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $2M | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -$1.2M | -- | -- | |
Cash From Financing | $37.9M | -- | -$1.2M | -$205K | -$93K | |
Beginning Cash (CF) | $4.8M | $34.6M | $25.2M | $25.5M | $8.3M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $37.9M | -$2.2M | -$5.9M | -$546K | $2.2M | |
Ending Cash (CF) | $42.7M | $32.3M | $19.3M | $24.9M | $10.4M | |
Levered Free Cash Flow | -$61K | -$2.2M | -$4.7M | -$341K | $3.1M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -$22.5M | -$21.3M | -$12.9M | -$16.6M | |
Depreciation & Amoritzation | -- | $2.6M | $3.3M | $3.4M | $3.7M | |
Stock-Based Compensation | $3.9M | $10.5M | $6.5M | $6.4M | $2.8M | |
Change in Accounts Receivable | -- | -$374K | -$449K | -$1.6M | -$435K | |
Change in Inventories | -- | -$842K | -$501K | -$11.7M | -$5.6M | |
Cash From Operations | -- | -$10.2M | -$10.8M | -$13.9M | -$6.4M | |
Capital Expenditures | $261K | $303K | $214K | $248K | $198K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -$303K | -$214K | -$248K | -$8.1M | |
Dividends Paid (Ex Special Dividend) | -$1.9M | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | $19.8M | $52K | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -$10.4M | -$13M | $5.6M | -$14.5M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -$10.5M | -$11.1M | -$14.2M | -$6.6M |
Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$12.9M | -$15.7M | -$17.4M | -$10.5M | -$12.7M | |
Depreciation & Amoritzation | $2M | $2M | $2.6M | $2.6M | $2.8M | |
Stock-Based Compensation | $3.9M | $5.3M | $4.9M | $4.7M | $2M | |
Change in Accounts Receivable | $912K | -$794K | $1.4M | $1.4M | -$69K | |
Change in Inventories | -$8.1M | -$271K | -$3.1M | -$7.9M | -$6.1M | |
Cash From Operations | -$11.8M | -$8.2M | -$10.1M | -$9.2M | -$5.9M | |
Capital Expenditures | $261K | $198K | $58K | $191K | $153K | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$221K | -$198K | -$58K | -$191K | -$4.2M | |
Dividends Paid (Ex Special Dividend) | -$1.9M | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $12.4M | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -$2.4M | -- | -$98K | |
Cash From Financing | $50M | $170K | -$2.2M | $19.6M | -$94K | |
Beginning Cash (CF) | $12.2M | $111M | $85.8M | $48.1M | $42.9M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $38M | -$8.3M | -$12.3M | $10.2M | -$10.2M | |
Ending Cash (CF) | $50.2M | $102.8M | $73.5M | $58.4M | $32.7M | |
Levered Free Cash Flow | -$12.1M | -$8.4M | -$10.2M | -$9.4M | -$6.1M |
Signup to receive the latest stock alerts
2024 was another banner year for the US stock market,…
Carlos Slim made a splash in a surprising sector last…
There is a lot of humdrum in the market about…
Market Cap: $3.7T
P/E Ratio: 40x
Market Cap: $3.4T
P/E Ratio: 116x
Market Cap: $3.1T
P/E Ratio: 35x
Bright Minds Biosciences [DRUG] is down 4.28% over the past day.
Banco Macro SA [BMA] is up 0.88% over the past day.
Agrify [AGFY] is down 5.86% over the past day.